Gold Sponsor
Eppendorf SE
About Eppendorf
Eppendorf is a leading life science company. It was founded in Hamburg, Germany in 1945 and has more than 3,300 employees worldwide. The company has subsidiaries in 25 countries and is represented in all other markets by distributors.
Eppendorf – Stimulating Growth. Cultivating Solutions.
By exploiting the strong synergies in bioreactor technology and polymer manufacturing, Eppendorf has grown to a global player in the bioprocess marketplace. With a comprehensive offering of single-use and traditional products, the Eppendorf bioprocess portfolio satisfies the demands from research and development through the production of mammalian, microbial, insect, plant and algae cells.
Associated Experts
Job Title: Project Leader
Job Title: Product Manager, Bioprocess Solutions
Job Title: Head of Bioprocess Applications
Job Title: Innovation Manager, Automation and Software
Job Title: Head of Portfolio and Applications
Associated Content
Unlocking Digital Transformation in Bioprocessing: Insights and Best Practices
Digitalization in the bioprocess industry brings unique challenges and immense potential, as organizations navigate complex systems that bridge production, R&D, and regulatory environments. Integrating digital tools with bioprocessing requires more than technology—it demands a clear ... Continued
Unlocking the Potential of Induced Pluripotent Stem Cells: Innovations, Challenges, and Future Directions
In this podcast, we spoke with Dr. Jorge Escobar Ivirico, Product Manager, Bioprocess Solutions at Eppendorf, about the fascinating world of induced pluripotent stem cells (iPSCs), exploring their groundbreaking potential in regenerative medicine, personalized therapies, ... Continued
Streamlining Lab Sampling: Tackling Challenges with Automation Using the Bioprocess Autosampler
Laboratory sampling is a critical step in the research and development process, yet it remains a source of significant challenges for many labs. From inconsistent sampling intervals and operator variability to inefficiencies in manual processes, ... Continued
Advancements in Cell and Gene Therapy: Innovations in Stem Cell Cultivation and Bioprocessing
Cell and Gene Therapy (CGT) represents an emerging frontier in transformative medicine, offering the potential to cure a variety of genetic and acquired diseases through the restoration or reconditioning of cells and genes. Unlike traditional ... Continued
Accelerating Bioprocess through Digital Transformation: A Strategic Path Forward
In an era where industries are increasingly driven by data and automation, the bioprocessing sector is embracing digital transformation to streamline workflows and improve productivity. However, blending the complex and highly regulated world of bioprocess ... Continued
Best Practices for Cell and Gene Therapy Biomanufacturing
Cell and gene therapies (CGTs) are a revolutionary approach in regenerative medicine, offering potential curative treatments for a range of diseases. With the rapid expansion of research and development in this field, there's a growing ... Continued
Boosting iPSC Numbers Using Methodical Optimization of Culture Processes
Human induced pluripotent stem cells (hiPSCs) are invaluable for various applications like drug discovery and disease modeling but require obtaining high cell numbers to be feasible. Achieving these high cell densities are challenging with 2D ... Continued
Build Powerful Upstream Bioprocesses for Cell and Gene Therapy Development
The field of cell and gene therapies (CGT) aims to treat diseases by restoring or reconditioning cells or genes, with cell and gene therapies differing in their mechanism of action. Despite being in the early ... Continued
Elevating Cell and Gene Therapy Workflows with Efficient Solutions for Cell Culture and Expansion
Cell and gene therapy (CGT) represents a paradigm shift in medicine, offering potential cures for diseases that traditional approaches struggle to address, particularly monogenic diseases. Unlike conventional treatments, CGT aims to restore or modify cells ... Continued
Production of MSC-Derived Exosomes Using Bioreactor Systems and Controllers
Mesenchymal stem cells (MSCs) have been at the epicenter of regenerative medicine since their identification in the 1970s, due to their ability to differentiate into various mesoderm-derived cell types, their immunomodulatory function through paracrine factors ... Continued
Advancements in Cell and Gene Therapy Stirred-Tank Bioreactor Suspension Culture
In this podcast, we talked with Dr. Ma Sha, Head of Bioprocess Applications at Eppendorf SE about advancements and challenges in cell and gene therapy production along with solutions for scale up and transition to ... Continued
How Stirred Tank Bioreactors and Bioprocess Controllers can Enable Efficient Automation and Scale-Up to Streamline Bioprocess Optimization
For decades, the biopharmaceutical industry has relied on mammalian cells, particularly Chinese Hamster Ovary (CHO) cells, to produce therapeutic proteins, which requires the establishment of robust and scalable manufacturing processes. Development typically starts in the ... Continued
Improving Upstream Bioprocessing Efficiency with Digital Tools
Digitalization holds great promise for increasing the efficiency, quality, and reproducibility of upstream bioprocessing. From automating a bioprocess run, process optimization through modeling and statistical methods, digital solutions for equipment maintenance, and cloud-based data handling, ... Continued
The Reproducibility Challenge in Bioprocessing
Achieving bioprocess reproducibility in cell culture-based production environments that are inherently variable can be frustrating for biomanufacturers. Not only that, it also contributes to increased batch costs, overall process inefficiencies and extended timelines. As an ... Continued
Bioprocessing Solutions to Accelerate Mammalian Cell-Based Vaccine Development
Vaccination remains one of the most effective methods to combat infectious viral diseases such as influenza. The recent COVID-19 crisis has placed unprecedented pressure on the vaccine industry to develop and deploy vaccines against emergent ... Continued
Examining Bioprocessing Scale-Up Challenges and Technology Solutions
The number of novel cell and gene therapeutics gaining regulatory approval is on the rise to treat a variety of human diseases. Yet, these complex biologics-based therapies present challenges for drug companies as to the ... Continued
DASbox Mini Bioreactor System’s small working volumes and advanced control options offer a versatile solution for advanced process development experiments
The DASbox was designed to enable parallel operation to streamline process development and DoE, while still offering the advanced controls found in industrial bioreactors....Continued
Successful Exosome Production Using Stem Cell Culture in Stirred Tank Bioreactors
In a recent study, Eppendorf used a combination of the SciVario® twin bioreactor control system and the BioBlu 1c single-use vessels as a model for large-scale exosome production in bioreactors....Continued
Next Generation Bioprocess Controller SciVario® Twin Provides Flexible Solution to Address Current and Future Needs
The SciVario twin was designed to control both small- and bench-scale bioreactors to enable efficient scale-up. Thus, enabling growth and adaptation as the process evolves. The system is equipped to handle future software updates and hardware extension releases, allowing the system to evolve with processes without requiring additional investments in new control systems....Continued
Keys to successful single-use bioreactor scale up – from small scale to pilot scale
Successful monoclonal antibody (mAb) manufacturing relies on good process development and reliable bioreactor scale up. Initial process development work is typically conducted at small scale, then moved to bench scale and lastly to pilot scale ... Continued
Advanced Bioprocess Controller Puts Cell Culture on Autopilot
Eppendorf is looking to make life easier for those working in bioprocessing labs by reducing training time and providing pre-set culture processes in the BioFlo® 120 bioprocess control station....Continued
Scalable Production of hiPSC-Derived Cardiomyocytes in Stirred-Tank Bioreactors
As part of our continuing conference coverage of the International Society of Cell & Gene Therapy 2018 held in Montreal, QC, we like to highlight interesting posters from the event. One such poster, “Scalable Production ... Continued
State of the Art CO2 Incubators Offer Safe Haven for Sensitive Cells
Cell culture CO2 incubators are a critical part of the cell culture process as cells spend most of their time here. The CO2 incubator’s purpose is to create ideal living conditions for cells to thrive, ... Continued
A Defined Synthetic Growth Surface for Stable hiPSC Expansion
Introduction hiPSCs cultivation can be challenging with lot-to-lot coating variations, tedious preparation and increased contamination risk. In particular, biological coatings may negatively impact downstream applications due to the presence of undefined extracellular matrix (ECM) components and ... Continued